CalciMedica, Inc.
CALC
$4.50
-$0.19-4.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -31.22% | 13.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.15% | 1.91% | |||
| Operating Income | 15.15% | -1.91% | |||
| Income Before Tax | -31.03% | -18.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.03% | -18.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.03% | -18.13% | |||
| EBIT | 15.15% | -1.91% | |||
| EBITDA | 15.15% | -1.93% | |||
| EPS Basic | -30.31% | -11.26% | |||
| Normalized Basic EPS | -30.34% | -11.20% | |||
| EPS Diluted | -30.31% | -10.33% | |||
| Normalized Diluted EPS | -30.34% | -11.20% | |||
| Average Basic Shares Outstanding | 0.54% | 6.19% | |||
| Average Diluted Shares Outstanding | 0.54% | 6.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||